ACVRX
Price
$12.41
Change
+$0.10 (+0.81%)
Updated
Jun 12 closing price
Net Assets
1.33B
TRWTX
Price
$28.27
Change
+$0.13 (+0.46%)
Updated
Jun 12 closing price
Net Assets
4.29B
Interact to see
Advertisement

ACVRX vs TRWTX

Header iconACVRX vs TRWTX Comparison
Open Charts ACVRX vs TRWTXBanner chart's image
ACVRX vs TRWTX Comparison Chart in %
View a ticker or compare two or three
VS
ACVRX vs. TRWTX commentary
Jun 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACVRX is a Buy and TRWTX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
TRWTX has more cash in the bank: 4.29B vs. ACVRX (1.33B). TRWTX pays higher dividends than ACVRX: TRWTX (3.44) vs ACVRX (2.60). ACVRX was incepted earlier than TRWTX: ACVRX (20 years) vs TRWTX (34 years). ACVRX (1.62) is less costly to investors than TRWTX (0.76). ACVRX is a more actively managed with annual turnover of: 79.00 vs. TRWTX (13.00). TRWTX has a lower initial minimum investment than ACVRX: TRWTX (0) vs ACVRX (2500). ACVRX annual gain was more profitable for investors over the last year : 22.21 vs. TRWTX (18.80). ACVRX return over 5 years is better than : 57.49 vs. TRWTX (44.72).
ACVRXTRWTXACVRX / TRWTX
Total Expense Ratio1.620.76213%
Annual Report Gross Expense Ratio1.620.76213%
Fund Existence20 years34 years-
Gain YTD12.21511.800104%
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.33B4.29B31%
Annual Yield % from dividends2.603.4476%
Returns for 1 year22.2118.80118%
Returns for 3 years69.0454.59126%
Returns for 5 years57.4944.72129%
Returns for 10 years138.54116.81119%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WRBY26.460.60
+2.32%
Warby Parker
PODC4.260.06
+1.43%
PodcastOne
SWBI14.760.11
+0.75%
Smith & Wesson Brands
SOFI16.58-0.09
-0.54%
SoFi Technologies
MGRX0.36-0.01
-1.46%
Mangoceuticals Inc